busulfan has been researched along with Anemia, Cooley's in 45 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-four children with beta-thalassemia major received abatacept at a dose of 10 mg/kg intravenously on days -1, +5, +14, and +28 after HSCT in addition to calcineurin inhibitors and methylprednisolone." | 8.02 | Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. ( Dandoy, CE; Davies, SM; El-Bietar, J; Grimley, MS; Khandelwal, P; Lane, A; Yeh, RF; Yu, L, 2021) |
| "Thirty-four patients had thalassemia major and 4 had SCA." | 5.43 | Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience. ( Ben-Arush, M; Elhasid, R; Khalil, A; Rowe, JM; Zaidman, I, 2016) |
| "Twenty-four children with beta-thalassemia major received abatacept at a dose of 10 mg/kg intravenously on days -1, +5, +14, and +28 after HSCT in addition to calcineurin inhibitors and methylprednisolone." | 4.02 | Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. ( Dandoy, CE; Davies, SM; El-Bietar, J; Grimley, MS; Khandelwal, P; Lane, A; Yeh, RF; Yu, L, 2021) |
| " In 1990, a woman aged 20 years, presenting with beta-thalassemia major, underwent chemotherapy (busulfan and cyclophosphamide) and total body irradiation (TBI) before bone marrow transplantation (BMT), the donor being her 17-year-old HLA-compatible sister." | 3.74 | Allograft of ovarian cortex between two genetically non-identical sisters: case report. ( Demylle, D; Dolmans, MM; Donnez, J; Jadoul, P; Pirard, C; Squifflet, J; Van Langendonckt, A, 2007) |
| " Conditioning regimens consisted of busulfan and cyclophosphamide, followed by cyclosporine +/- methotrexate for graft-versus-host disease (GVHD) prophylaxis." | 3.74 | Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major. ( Alimoghaddam, K; Ashouri, A; Ghaffari, H; Ghavamzadeh, A; Hadjibabaie, M; Iravani, M; Mahdavi, N; Mousavi, SA; Namdar, R; Nedaeifard, L; Shamshiri, A, 2008) |
| "Busulfan (Bu) is a key component of the conditioning regimen prior to HSCT." | 2.82 | Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients. ( Ansari, M; Bittencourt, H; Cappelli, B; Duval, M; Huezo-Diaz, P; Krajinovic, M; Marktel, S; Rezgui, MA, 2016) |
| " This treosulfan-based preparation proved to be safe and effective for thalassemia patients given allogeneic HSCT." | 2.77 | Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. ( Bernardo, ME; Bertaina, A; Caocci, G; Contoli, B; Giorgiani, G; La Nasa, G; Locatelli, F; Mastronuzzi, A; Pagliara, D; Pinto, RM; Piras, E; Vacca, A; Zecca, M, 2012) |
| " The mean AUC, Css, Cmax and MRV were significantly higher in group B as compared with group A for both doses 1 and 13." | 2.69 | Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation. ( Aigrain, EJ; Chandy, M; Dennison, D; Kanagasabapathy, AS; Krishnamoorthy, R; Poonkuzhali, B; Quernin, MH; Srivastava, A, 1999) |
| "Thirty-four patients had thalassemia major and 4 had SCA." | 1.43 | Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience. ( Ben-Arush, M; Elhasid, R; Khalil, A; Rowe, JM; Zaidman, I, 2016) |
| "The only radical cure for thalassemia major patients today is the replacement of the defective hematopoietic system by allogeneic stem cell transplantation (allo-SCT)." | 1.34 | Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. ( Abdul-Hai, A; Ackerstein, A; Aker, M; Amar, A; Bitan, M; Gesundheit, B; Or, R; Resnick, IB; Samuel, S; Shapira, MY; Slavin, S; Tsirigotis, P, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (35.56) | 18.2507 |
| 2000's | 11 (24.44) | 29.6817 |
| 2010's | 15 (33.33) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lüftinger, R | 1 |
| Zubarovskaya, N | 1 |
| Galimard, JE | 1 |
| Cseh, A | 1 |
| Salzer, E | 1 |
| Locatelli, F | 3 |
| Algeri, M | 1 |
| Yesilipek, A | 1 |
| de la Fuente, J | 1 |
| Isgrò, A | 1 |
| Alseraihy, A | 1 |
| Angelucci, E | 5 |
| Smiers, FJ | 1 |
| La La Nasa, G | 1 |
| Zecca, M | 3 |
| Fisgin, T | 1 |
| Unal, E | 1 |
| Kleinschmidt, K | 1 |
| Peters, C | 1 |
| Lankester, A | 1 |
| Corbacioglu, S | 1 |
| Kulkarni, UP | 1 |
| Pai, AA | 1 |
| Kavitha, ML | 1 |
| Selvarajan, S | 1 |
| Lionel, S | 1 |
| Devasia, AJ | 1 |
| Korula, A | 3 |
| Fouzia, NA | 2 |
| Sindhuvi, E | 3 |
| Abraham, A | 4 |
| Srivastava, A | 8 |
| Mathews, V | 5 |
| George, B | 5 |
| Balasubramanian, P | 3 |
| Khandelwal, P | 1 |
| Yeh, RF | 1 |
| Yu, L | 1 |
| Lane, A | 1 |
| Dandoy, CE | 1 |
| El-Bietar, J | 1 |
| Davies, SM | 1 |
| Grimley, MS | 1 |
| Pn, N | 1 |
| Devasia, A | 1 |
| Lakshmi, KM | 3 |
| Edison, ES | 1 |
| Velayudhan, SR | 1 |
| Viswabandya, A | 2 |
| Dighe, NM | 1 |
| Tan, KW | 1 |
| Tan, LG | 1 |
| Shaw, SSW | 1 |
| Buckley, SMK | 1 |
| Sandikin, D | 1 |
| Johana, N | 1 |
| Tan, YW | 1 |
| Biswas, A | 1 |
| Choolani, M | 1 |
| Waddington, SN | 1 |
| Antoniou, MN | 1 |
| Chan, JKY | 1 |
| Mattar, CNZ | 1 |
| Sun, Q | 1 |
| Wu, B | 1 |
| Lan, H | 1 |
| Meng, F | 1 |
| Ma, X | 1 |
| Chen, X | 1 |
| Huang, Z | 1 |
| Yao, Q | 1 |
| Xu, J | 1 |
| Huang, Y | 1 |
| Wu, S | 1 |
| Zhu, Z | 1 |
| Andreani, M | 3 |
| Gregori, S | 1 |
| Sun, L | 1 |
| Wang, N | 1 |
| Chen, Y | 1 |
| Tang, L | 1 |
| Xing, C | 1 |
| Lu, N | 1 |
| Shi, Y | 1 |
| Ma, Y | 1 |
| Lin, F | 1 |
| Yu, K | 1 |
| Feng, J | 1 |
| Hussein, AA | 1 |
| Al-Zaben, A | 1 |
| Ghatasheh, L | 1 |
| Natsheh, A | 1 |
| Hammada, T | 1 |
| Abdel-Rahman, F | 1 |
| Abu-Jazar, H | 1 |
| Sharma, S | 1 |
| Najjar, R | 1 |
| Frangoul, H | 1 |
| Ahmed, R | 1 |
| Ganapule, A | 1 |
| Ansari, M | 1 |
| Huezo-Diaz, P | 1 |
| Rezgui, MA | 1 |
| Marktel, S | 3 |
| Duval, M | 1 |
| Bittencourt, H | 1 |
| Cappelli, B | 3 |
| Krajinovic, M | 1 |
| Zaidman, I | 1 |
| Rowe, JM | 1 |
| Khalil, A | 1 |
| Ben-Arush, M | 1 |
| Elhasid, R | 1 |
| Bernardo, ME | 2 |
| Piras, E | 2 |
| Vacca, A | 4 |
| Giorgiani, G | 2 |
| Cugno, C | 1 |
| Caocci, G | 2 |
| Comoli, P | 1 |
| Mastronuzzi, A | 2 |
| Merli, P | 1 |
| La Nasa, G | 4 |
| Chiesa, R | 2 |
| Evangelio, C | 2 |
| Biffi, A | 2 |
| Roccia, T | 2 |
| Frugnoli, I | 2 |
| Biral, E | 2 |
| Noè, A | 2 |
| Fossati, M | 2 |
| Finizio, V | 2 |
| Miniero, R | 2 |
| Napolitano, S | 1 |
| Ferrua, F | 1 |
| Soliman, C | 1 |
| Ciceri, F | 2 |
| Roncarolo, MG | 2 |
| Crocchiolo, R | 1 |
| Aiuti, A | 1 |
| Broglia, M | 1 |
| Bartoli, A | 1 |
| Donnez, J | 2 |
| Squifflet, J | 2 |
| Pirard, C | 2 |
| Jadoul, P | 2 |
| Dolmans, MM | 2 |
| Bertaina, A | 1 |
| Pagliara, D | 1 |
| Contoli, B | 1 |
| Pinto, RM | 1 |
| Galambrun, C | 1 |
| Pondarré, C | 1 |
| Bertrand, Y | 1 |
| Loundou, A | 1 |
| Bordigoni, P | 1 |
| Frange, P | 1 |
| Lutz, P | 1 |
| Mialou, V | 1 |
| Rubie, H | 1 |
| Socié, G | 1 |
| Schneider, P | 1 |
| Bernaudin, F | 1 |
| Paillard, C | 1 |
| Michel, G | 1 |
| Badens, C | 1 |
| Thuret, I | 1 |
| Choudhary, D | 1 |
| Sharma, SK | 1 |
| Gupta, N | 1 |
| Kharya, G | 1 |
| Pavecha, P | 1 |
| Handoo, A | 1 |
| Setia, R | 1 |
| Katewa, S | 1 |
| Poonkuzhali, B | 3 |
| Shaji, RV | 1 |
| Chandy, M | 4 |
| Krishnamoorthy, R | 4 |
| Hongeng, S | 1 |
| Pakakasama, S | 1 |
| Chaisiripoomkere, W | 1 |
| Ungkanont, A | 1 |
| Jootar, S | 1 |
| Roberts, C | 1 |
| Kean, L | 1 |
| Archer, D | 1 |
| Balkan, C | 1 |
| Hsu, LL | 1 |
| Zhu, KE | 1 |
| Li, JP | 1 |
| Zhang, T | 1 |
| Zhong, J | 1 |
| Chen, J | 1 |
| Van Langendonckt, A | 1 |
| Demylle, D | 1 |
| Resnick, IB | 1 |
| Aker, M | 1 |
| Tsirigotis, P | 1 |
| Shapira, MY | 1 |
| Abdul-Hai, A | 1 |
| Bitan, M | 1 |
| Gesundheit, B | 1 |
| Amar, A | 1 |
| Ackerstein, A | 1 |
| Samuel, S | 1 |
| Slavin, S | 1 |
| Or, R | 1 |
| Ghavamzadeh, A | 2 |
| Iravani, M | 1 |
| Ashouri, A | 1 |
| Mousavi, SA | 1 |
| Mahdavi, N | 1 |
| Shamshiri, A | 1 |
| Hadjibabaie, M | 1 |
| Namdar, R | 1 |
| Nedaeifard, L | 1 |
| Ghaffari, H | 1 |
| Alimoghaddam, K | 1 |
| Jahani, M | 1 |
| Baybordi, E | 1 |
| Manna, M | 1 |
| Nesci, S | 1 |
| Tonucci, P | 1 |
| Lucarelli, G | 5 |
| Contu, L | 2 |
| Arras, M | 2 |
| Ledda, A | 2 |
| Pizzati, A | 2 |
| Carcassi, C | 2 |
| Floris, L | 1 |
| Porcella, R | 1 |
| Orrù, S | 2 |
| Galimberti, M | 4 |
| De Sanctis, V | 2 |
| Polchi, P | 3 |
| Baronciani, D | 4 |
| Giardini, C | 3 |
| Erer, B | 2 |
| Gaziev, J | 1 |
| Balducci, R | 1 |
| Ughi, M | 1 |
| Vullo, C | 1 |
| Bagni, B | 1 |
| Mulargia, M | 1 |
| Boero, R | 1 |
| Vassallo, E | 1 |
| Busca, A | 1 |
| Piga, A | 1 |
| Perugini, L | 1 |
| Madon, E | 1 |
| Tang-naitrisorana, Y | 1 |
| Issaragrisil, S | 1 |
| Visuthisakchai, S | 1 |
| Suvatte, V | 1 |
| Piankijakum, A | 1 |
| Lal, A | 1 |
| Pati, HP | 1 |
| Arya, LS | 1 |
| Choudhry, VP | 1 |
| Gaziev, D | 1 |
| Maiello, A | 1 |
| Borgna-Pignatti, C | 1 |
| Marradi, P | 1 |
| Rugolotto, S | 1 |
| Marcolongo, A | 1 |
| Pawlowska, AB | 1 |
| Blazar, BR | 1 |
| Shu, XO | 1 |
| Bostrom, B | 1 |
| Lee, YS | 1 |
| Kristovich, KM | 1 |
| Ducore, JM | 1 |
| Vichinsky, E | 1 |
| Crouse, VL | 1 |
| Glader, BE | 1 |
| Amylon, MD | 1 |
| Li, CK | 1 |
| Yuen, PM | 1 |
| Wong, R | 1 |
| Pang, CP | 1 |
| Lai, WK | 1 |
| Law, E | 1 |
| Shing, MM | 1 |
| Chik, KW | 1 |
| Leung, TF | 1 |
| Quernin, MH | 1 |
| Dennison, D | 2 |
| Aigrain, EJ | 1 |
| Kanagasabapathy, AS | 1 |
| Zambruno, G | 1 |
| Girolomoni, G | 1 |
| Manca, V | 1 |
| Giannetti, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Multicentre, Randomized, Controlled Open-label Study on the Use of Anti-thymocyte Globulin and Rituximab for Immunomodulation of Graft-versus-host Disease in Allogeneic Matched Transplants for Non Malignancies[NCT01810926] | Phase 2 | 130 participants (Anticipated) | Interventional | 2011-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 trials available for busulfan and Anemia, Cooley's
| Article | Year |
|---|---|
Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen.
Topics: Adult; Allografts; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; beta-Thalas | 2018 |
Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
Topics: Acute Disease; Adult; Allografts; Antilymphocyte Serum; beta-Thalassemia; Busulfan; Child; Child, Pr | 2019 |
Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.
Topics: Adolescent; Adult; Antilymphocyte Serum; beta-Thalassemia; Busulfan; Child; Child, Preschool; Cyclop | 2013 |
Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients.
Topics: Alleles; Allografts; beta-Thalassemia; Busulfan; Child; Female; Genotype; Glutathione Transferase; H | 2016 |
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Child; Child, Preschool; Drug Therapy, Combination; F | 2008 |
Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policy.
Topics: Adolescent; beta-Thalassemia; Busulfan; Child; Child, Preschool; Dose-Response Relationship, Drug; F | 2010 |
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Child; Child, Preschool; Cohort Studies; Female; Graf | 2012 |
French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Child, Preschool; Cyclophosphamide; Disease-Free Surv | 2013 |
Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclop | 2004 |
Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.
Topics: Adolescent; Adult; Antilymphocyte Serum; beta-Thalassemia; Bone Marrow; Bone Marrow Purging; Bone Ma | 1993 |
Effect of myleran therapy in multitransfused thalassemic children.
Topics: Adolescent; beta-Thalassemia; Blood Cell Count; Blood Transfusion; Busulfan; Child; Child, Preschool | 1995 |
Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; beta-Thalassemia; Bone Marrow Transpl | 1997 |
Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation.
Topics: Administration, Oral; Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Ch | 1999 |
Glutathione S-transferase activity influences busulfan pharmacokinetics in patients with beta thalassemia major undergoing bone marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Enzyme | 2001 |
31 other studies available for busulfan and Anemia, Cooley's
| Article | Year |
|---|---|
Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.
Topics: Adolescent; Antineoplastic Agents; beta-Thalassemia; Busulfan; Child; Child, Preschool; Female; Hema | 2022 |
Endothelial Activation and Stress Index-Measured Pretransplantation Predicts Transplantation-Related Mortality in Patients with Thalassemia Major Undergoing Transplantation with Thiotepa, Treosulfan, and Fludarabine Conditioning.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Child; Child, Preschool; Female; Humans; Infant; Male | 2022 |
Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa.
Topics: Abatacept; Adolescent; beta-Thalassemia; Busulfan; Calcineurin Inhibitors; Child; Child, Preschool; | 2021 |
Second Hematopoietic Stem Cell Transplant for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan-Based Conditioning Regimen.
Topics: Adolescent; beta-Thalassemia; Busulfan; Child; Child, Preschool; Female; Graft Rejection; Hematopoie | 2018 |
Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Child; Child, Preschool; Chimerism; Cyclophosphamide; | 2018 |
A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.
Topics: Animals; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Cell Survival; Cellular Microenvir | 2018 |
The study of engraftment after hematopoietic stem cell transplantation: From the presence of mixed chimerism to the development of immunological tolerance.
Topics: Antigens, CD; beta-Thalassemia; Busulfan; Cohort Studies; Cyclophosphamide; Gene Expression; Graft R | 2018 |
Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Cells; Busulfan; Cause of Death; Child; Child, Preschool; | 2013 |
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Topics: Adolescent; Adult; Anemia, Sickle Cell; beta-Thalassemia; Busulfan; Child; Child, Preschool; Chimeri | 2016 |
Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan.
Topics: Adolescent; beta-Thalassemia; Busulfan; Child; Child, Preschool; Drug Evaluation; Female; Graft vs H | 2009 |
Restoration of ovarian function after allografting of ovarian cortex between genetically non-identical sisters.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antineoplastic Agents, Alkylating; beta-Thalassemia; Busulfa | 2010 |
Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
Topics: Adolescent; beta-Thalassemia; Busulfan; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host | 2013 |
Nonmyeloablative stem cell transplantation with a haploidentical donor in a class 3 lucarelli severe thalassemia patient.
Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Busulfan; Female; Feta | 2004 |
Murine and math models for the level of stable mixed chimerism to cure beta-thalassemia by nonmyeloablative bone marrow transplantation.
Topics: Animals; Animals, Congenic; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Erythrocyte Cou | 2005 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig | 2007 |
Allograft of ovarian cortex between two genetically non-identical sisters: case report.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Combined Modality Therapy; Cyclophosphamide; Female; | 2007 |
Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
Topics: Adolescent; Adult; Antilymphocyte Serum; beta-Thalassemia; Busulfan; Child; Child, Preschool; Female | 2007 |
Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Topics: Acute Disease; Adolescent; beta-Thalassemia; Blood Platelets; Bone Marrow Transplantation; Busulfan; | 2008 |
Bone marrow transplantation in Iran.
Topics: Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; | 1994 |
Successful unrelated bone marrow transplantation in beta-thalassaemia.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cycl | 1994 |
Pancreatic beta-cell function before and after bone marrow transplantation for thalassemia.
Topics: Adolescent; Adrenal Cortex Hormones; beta-Thalassemia; Bone Marrow Purging; Bone Marrow Transplantat | 1993 |
Gonadal function in long term survivors with B thalassemia major following bone marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Chi | 1993 |
Bone marrow transplantation in thalassemia. The Cagliari team experience.
Topics: Adolescent; Adult; beta-Thalassemia; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Chi | 1993 |
Bone marrow transplantation for children with thalassemia: two years' experience with low-dose busulfan, citoxan and GM-CSF.
Topics: Adolescent; Adult; beta-Thalassemia; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Chi | 1993 |
Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
Topics: beta-Thalassemia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cells, Cultured; Child; Child, | 1995 |
CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Thalassemia; Blood | 1996 |
Successful pregnancy after bone marrow transplantation for thalassaemia.
Topics: Adult; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Combined Modality | 1996 |
Bone marrow transplant in thalassemia. A role for radiation?
Topics: Adolescent; Adult; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; | 1998 |
Busulphan level and early mortality in thalassaemia patients after BMT.
Topics: Adolescent; Adult; beta-Thalassemia; Busulfan; Child; Child, Preschool; Hematopoietic Stem Cell Tran | 1999 |
Evaluation of existing limited sampling models for busulfan kinetics in children with beta thalassaemia major undergoing bone marrow transplantation.
Topics: Adolescent; Alkylating Agents; Area Under Curve; beta-Thalassemia; Bone Marrow Transplantation; Busu | 2001 |
Epidermal Langerhans cells after allogeneic bone marrow transplantation: depletion by chemotherapy conditioning regimen alone.
Topics: Adolescent; Adult; Antigens, CD; Antigens, CD1; beta-Thalassemia; Bone Marrow Transplantation; Busul | 1992 |